ACM Biolabs
Operator of a biotechnology company intended to develop novel vaccines using proprietary artificial cell membrane (ACM) technology. The company develops prophylactic and therapeutic vaccines for infec...
Interested in buying or selling ACM Biolabs shares?
Get a free quote from our secondary market team. We facilitate transactions from $250K to $500M+.
Valuation
$0
Share Price
N/A
Total Raised
$26M
Last Round
N/A